학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 10건 | 목록 1~10
Academic Journal
Giffen PS; Department of Respiratory & Immunology Toxicology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.; Kilgour JD; ApconiX, Macclesfield, UK.; Jacobsen M; Department of Pathology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.; Thacker K; Department of Regulatory Toxicology and Safety Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.; Holmberg AA; Department of Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publisher: Sage Publications Country of Publication: United States NLM ID: 9708436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1092-874X (Electronic) Linking ISSN: 10915818 NLM ISO Abbreviation: Int J Toxicol Subsets: MEDLINE
Academic Journal
Holmberg AA; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.) ann.aurellholmberg1@astrazeneca.com.; Weidolf L; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.).; Necander S; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.).; Bold P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.).; Sidhu S; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.).; Pelay-Gimeno M; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.).; de Ligt RAF; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.).; Verheij ER; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.).; Jauhiainen A; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.).; Psallidas I; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.).; Wählby Hamrén U; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.).; Prothon S; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (A.A.H., S.N., P.B.), Cardiovascular, Renal and Metabolism (L.W.), BioPharma Early Biometrics and Statistical Innovation, Data Science and AI (A.J.), and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Science (U.W.H., S.P.), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Quotient Sciences, Nottingham, United Kingdom (S.S.); TNO, Leiden, The Netherlands (M.P.-G., R.A.F.d.L., E.R.V.); and Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom (I.P.).
Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: United States NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE
Academic Journal
Holmberg AA; AstraZeneca R&D, Mölndal, Sweden.; Ekdahl AWeidolf L
Publisher: American Society for Pharmacology and Experimental Therapeutics, etc.] Country of Publication: United States NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE
Academic Journal
Fransson B; AstraZeneca R&D, Södertälje, Sweden.; Silberg DGNiazi MMiller FRuth MHolmberg AA
Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN: 0946-1965 (Print) Linking ISSN: 09461965 NLM ISO Abbreviation: Int J Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Niazi M; AstraZeneca R&D, Mölndal, Sweden. Mohammad.Niazi@astrazeneca.com; Skrtic SRuth MHolmberg AA
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print Cited Medium: Internet ISSN: 1179-6901 (Electronic) Linking ISSN: 11745886 NLM ISO Abbreviation: Drugs R D Subsets: MEDLINE
Academic Journal
Niazi M; AstraZeneca RD, Mölndal, Sweden. Mohammad.Niazi@astrazeneca.com; Silberg DGMiller FRuth MHolmberg AA
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print Cited Medium: Internet ISSN: 1179-6901 (Electronic) Linking ISSN: 11745886 NLM ISO Abbreviation: Drugs R D Subsets: MEDLINE
Academic Journal
Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
Academic Journal
Abelö A; AstraZeneca R&D Mölndal, Mölndal, Sweden. angela.abelo@astrazeneca.com; Andersson MHolmberg AAKarlsson MO
Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0928-0987 (Print) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE
Academic Journal
Lehmann A; Integrative Pharmacology, Gastrointestinal Biology, AstraZeneca R&D Mölndal, Mölndal, Sweden. anders.lehmann@astrazeneca.com; Holmberg AABhatt UBremner-Danielsen MBrändén LElg SElebring TFitzpatrick KGeiss WBGuzzo PJensen JJerndal GMattsson JPNilsson KOlsson BM
Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print Cited Medium: Print ISSN: 0007-1188 (Print) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Holmberg AA
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어